One of my main concerns was that the company would begin running the OncoType DX test on my tumor when my insurance has not agreed to cover it.
The good news is that isn’t happening because, as of Friday, MD Anderson STILL hadn’t sent my tumor.
The bad news is that, as of Friday, MD Anderson STILL hadn’t sent my tumor.